Journal Logo

February 2021 - Volume 31 - Issue 1
pp: 1-103

Basic Science

MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas

Murria Estal, Rosa; de Unamuno Bustos, Blanca; Pérez Simó, Gema; More

Melanoma Research. 31(1):18-26, February 2021.

Translational Research

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target

Bao, Riyue; Surriga, Oliver; Olson, Daniel J.; More

Melanoma Research. 31(1):27-37, February 2021.

Clinical Research

Clinical outcomes and secondary glaucoma after gamma-knife radiosurgery and Ruthenium-106 brachytherapy for uveal melanoma: a single institution experience

Mazzini, Cinzia; Pieretti, Giulia; Vicini, Giulio; More

Melanoma Research. 31(1):38-48, February 2021.

Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients

Cybulska-Stopa, Bozena; Zietek, Marcin; Kaminska-Winciorek, Grazyna; More

Melanoma Research. 31(1):49-57, February 2021.

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases

Ismail, Rawa K.; Sikkes, Nienke O.; Wouters, Michel W.J.M.; More

Melanoma Research. 31(1):58-66, February 2021.

Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)

Hodi, F. Stephen; Chapman, Paul B.; Sznol, Mario; More

Melanoma Research. 31(1):67-75, February 2021.